The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, first-in-human, phase I trial of the safety and efficacy of daily PCLX-001.
 
Randeep S. Sangha
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Roche/Genentech; Takeda; Teva
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck Serono (Inst); MorphoSys (Inst); Novartis (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
 
Laurie Helen Sehn
Honoraria - Abbvie; Acerta Pharma; Amgen; Apobiologix; AstraZeneca; Celgene; Gilead Sciences; Janssen-Ortho; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; morphosys; Roche/Genentech; Seagen; Seagen; Takeda; Takeda; Teva; TG Therapeutics
Consulting or Advisory Role - Abbvie; Acerta Pharma; Amgen; Amgen; apobiologix; AstraZeneca; Celgene; Gilead Sciences; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; MorphoSys; Roche/Genentech; Seagen; Takeda; Teva; TG Therapeutics; TG therapeutics
Research Funding - Roche/Genentech (Inst)
 
John Kuruvilla
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Karyopharm Therapeutics; Merck; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Gilead Sciences; Karyopharm Therapeutics; Merck; Roche; Seagen
Research Funding - Celgene; Janssen; Roche
 
Michael Weickert
Employment - Pacylex
Leadership - Pacylex
Stock and Other Ownership Interests - Pacylex
 
John Robert Mackey
Stock and Other Ownership Interests - illumiSonics; Pacylex; SMHeartCard
Honoraria - Pfizer
Patents, Royalties, Other Intellectual Property - Patents surrounding technology related to SMHeartCard Inc.
Travel, Accommodations, Expenses - illumiSonics; Pacylex
 
Luc G. Berthiaume
Stock and Other Ownership Interests - Pacylex
Patents, Royalties, Other Intellectual Property - Pacylex
Travel, Accommodations, Expenses - Pacylex
(OPTIONAL) Uncompensated Relationships - Pacylex